Update Breast Cancer 2022 Part 5 - Early Stage Breast Cancer

Tanja N Fehm; Manfred Welslau; Volkmar Müller; Diana Lüftner; Florian Schütz; Peter A Fasching; Wolfgang Janni; Christoph Thomssen; Isabell Witzel; Milena Beierlein; Erik Belleville; Michael Untch; Marc Thill; Hans Tesch; Nina Ditsch; Michael P Lux; Bahriye Aktas; Maggie Banys-Paluchowski; Cornelia Kolberg-Liedtke; Andreas D Hartkopf; Achim Wöckel; Hans-Christian Kolberg; Nadia Harbeck; Elmar Stickeler

doi:10.1055/a-2018-9053

Update Breast Cancer 2022 Part 5 - Early Stage Breast Cancer

Tanja N Fehm, Manfred Welslau, Volkmar Müller, Diana Lüftner, Florian Schütz, Peter A Fasching, Wolfgang Janni, Christoph Thomssen, Isabell Witzel, Milena Beierlein, Erik Belleville, Michael Untch, Marc Thill, Hans Tesch, Nina Ditsch, Michael P Lux, Bahriye Aktas, Maggie Banys-Paluchowski, Cornelia Kolberg-Liedtke, Andreas D HartkopfAchim Wöckel, Hans-Christian Kolberg, Nadia Harbeck, Elmar Stickeler

2 Zitate (Scopus)

Abstract

The treatment of patients with early stage breast cancer has changed in recent years due to the introduction of pembrolizumab, olaparib, and abemaciclib. These and other drugs with the same class of active ingredient are currently in trial for various indications. This review article summarizes the latest results that have either been presented at major conferences such as the ESMO 2022 or published recently in international journals. This includes reports on newly discovered breast cancer genes, atezolizumab in neoadjuvant therapy in HER2-positive patients, long-term data from the APHINITY study, and on how preoperative peritumoral application of local anesthetics can influence the prognosis. We also present solid data on dynamic Ki-67 from the ADAPT studies.

Originalsprache	Englisch
Zeitschrift	Geburtshilfe und Frauenheilkunde
Jahrgang	83
Ausgabenummer	03
Seiten (von - bis)	289-298
Seitenumfang	10
ISSN	0016-5751
DOIs	https://doi.org/10.1055/a-2018-9053
Publikationsstatus	Veröffentlicht - 03.2023

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Zentren: Universitäres Cancer Center Schleswig-Holstein (UCCSH)
Profilbereich: Lübeck Integrated Oncology Network (LION)

DFG-Fachsystematik

2.22-14 Hämatologie, Onkologie
2.22-21 Gynäkologie und Geburtshilfe

Dokumente

10.1055/a-2018-9053

Weitere Links

Zitieren

Fehm, T. N., Welslau, M., Müller, V., Lüftner, D., Schütz, F., Fasching, P. A., Janni, W., Thomssen, C., Witzel, I., Beierlein, M., Belleville, E., Untch, M., Thill, M., Tesch, H., Ditsch, N., Lux, M. P., Aktas, B., Banys-Paluchowski, M., Kolberg-Liedtke, C., ... Stickeler, E. (2023). Update Breast Cancer 2022 Part 5 - Early Stage Breast Cancer. Geburtshilfe und Frauenheilkunde, 83(03), 289-298. https://doi.org/10.1055/a-2018-9053

@article{892dcf9759404aa2bbc3036b02861bee,

title = "Update Breast Cancer 2022 Part 5 - Early Stage Breast Cancer",

abstract = "The treatment of patients with early stage breast cancer has changed in recent years due to the introduction of pembrolizumab, olaparib, and abemaciclib. These and other drugs with the same class of active ingredient are currently in trial for various indications. This review article summarizes the latest results that have either been presented at major conferences such as the ESMO 2022 or published recently in international journals. This includes reports on newly discovered breast cancer genes, atezolizumab in neoadjuvant therapy in HER2-positive patients, long-term data from the APHINITY study, and on how preoperative peritumoral application of local anesthetics can influence the prognosis. We also present solid data on dynamic Ki-67 from the ADAPT studies.",

author = "Fehm, \{Tanja N\} and Manfred Welslau and Volkmar M{\"u}ller and Diana L{\"u}ftner and Florian Sch{\"u}tz and Fasching, \{Peter A\} and Wolfgang Janni and Christoph Thomssen and Isabell Witzel and Milena Beierlein and Erik Belleville and Michael Untch and Marc Thill and Hans Tesch and Nina Ditsch and Lux, \{Michael P\} and Bahriye Aktas and Maggie Banys-Paluchowski and Cornelia Kolberg-Liedtke and Hartkopf, \{Andreas D\} and Achim W{\"o}ckel and Hans-Christian Kolberg and Nadia Harbeck and Elmar Stickeler",

note = "The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).",

year = "2023",

month = mar,

doi = "10.1055/a-2018-9053",

language = "English",

volume = "83",

pages = "289--298",

journal = "Geburtshilfe und Frauenheilkunde",

issn = "0016-5751",

publisher = "Georg Thieme Verlag",

number = "03",

}

Fehm, TN, Welslau, M, Müller, V, Lüftner, D, Schütz, F, Fasching, PA, Janni, W, Thomssen, C, Witzel, I, Beierlein, M, Belleville, E, Untch, M, Thill, M, Tesch, H, Ditsch, N, Lux, MP, Aktas, B, Banys-Paluchowski, M, Kolberg-Liedtke, C, Hartkopf, AD, Wöckel, A, Kolberg, H-C, Harbeck, N & Stickeler, E 2023, 'Update Breast Cancer 2022 Part 5 - Early Stage Breast Cancer', Geburtshilfe und Frauenheilkunde, Jg. 83, Nr. 03, S. 289-298. https://doi.org/10.1055/a-2018-9053

TY - JOUR

T1 - Update Breast Cancer 2022 Part 5 - Early Stage Breast Cancer

AU - Fehm, Tanja N

AU - Welslau, Manfred

AU - Müller, Volkmar

AU - Lüftner, Diana

AU - Schütz, Florian

AU - Fasching, Peter A

AU - Janni, Wolfgang

AU - Thomssen, Christoph

AU - Witzel, Isabell

AU - Beierlein, Milena

AU - Belleville, Erik

AU - Untch, Michael

AU - Thill, Marc

AU - Tesch, Hans

AU - Ditsch, Nina

AU - Lux, Michael P

AU - Aktas, Bahriye

AU - Banys-Paluchowski, Maggie

AU - Kolberg-Liedtke, Cornelia

AU - Hartkopf, Andreas D

AU - Wöckel, Achim

AU - Kolberg, Hans-Christian

AU - Harbeck, Nadia

AU - Stickeler, Elmar

N1 - The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).

PY - 2023/3

Y1 - 2023/3

N2 - The treatment of patients with early stage breast cancer has changed in recent years due to the introduction of pembrolizumab, olaparib, and abemaciclib. These and other drugs with the same class of active ingredient are currently in trial for various indications. This review article summarizes the latest results that have either been presented at major conferences such as the ESMO 2022 or published recently in international journals. This includes reports on newly discovered breast cancer genes, atezolizumab in neoadjuvant therapy in HER2-positive patients, long-term data from the APHINITY study, and on how preoperative peritumoral application of local anesthetics can influence the prognosis. We also present solid data on dynamic Ki-67 from the ADAPT studies.

AB - The treatment of patients with early stage breast cancer has changed in recent years due to the introduction of pembrolizumab, olaparib, and abemaciclib. These and other drugs with the same class of active ingredient are currently in trial for various indications. This review article summarizes the latest results that have either been presented at major conferences such as the ESMO 2022 or published recently in international journals. This includes reports on newly discovered breast cancer genes, atezolizumab in neoadjuvant therapy in HER2-positive patients, long-term data from the APHINITY study, and on how preoperative peritumoral application of local anesthetics can influence the prognosis. We also present solid data on dynamic Ki-67 from the ADAPT studies.

UR - https://www.scopus.com/pages/publications/85150443485

UR - https://www.mendeley.com/catalogue/fb11c006-8249-3fdd-b2cb-e40e49113b7c/

U2 - 10.1055/a-2018-9053

DO - 10.1055/a-2018-9053

M3 - Scientific review articles

C2 - 36908285

SN - 0016-5751

VL - 83

SP - 289

EP - 298

JO - Geburtshilfe und Frauenheilkunde

JF - Geburtshilfe und Frauenheilkunde

IS - 03

ER -

Update Breast Cancer 2022 Part 5 - Early Stage Breast Cancer

Abstract

UN SDGs

Strategische Forschungsbereiche und Zentren

DFG-Fachsystematik

Dokumente

Weitere Links

Fingerprint

Zitieren